# Therapeutic Apheresis and Dialysis

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/therapeutic-apheresis-and-dialysis/

## Facts

| Field | Value |
| --- | --- |
| APC (USD) | 3,350 |
| Citations | 41,793 |
| h-index | 71 |
| Homepage | https://onlinelibrary.wiley.com/journal/17449987 |
| Open Access | false |
| ISSN-L | 1091-6660 |
| ISSNs | 1091-6660,1526-0968,1744-9979,1744-9987 |
| OpenAlex ID | https://openalex.org/S185416529 |
| Publisher | Wiley |
| Works | 3,778 |

## Journal papers

Showing 12 of 17.

- [An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013)](https://scholariq.org/papers/an-overview-of-regular-dialysis-treatment-in-japan-as-of-31-december-2013/)
- [Clinical Practice Guideline for the Management of Chronic Kidney Disease‐Mineral and Bone Disorder](https://scholariq.org/papers/clinical-practice-guideline-for-the-management-of-chronic-kidney-disease-mineral/)
- [2008 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease](https://scholariq.org/papers/2008-japanese-society-for-dialysis-therapy-guidelines-for-renal-anemia-in/)
- [Overview of Regular Dialysis Treatment in Japan (as of 31 December 2008)](https://scholariq.org/papers/overview-of-regular-dialysis-treatment-in-japan-as-of-31-december-2008/)
- [Overview of Regular Dialysis Treatment in <scp>J</scp>apan (as of 31 <scp>D</scp>ecember 2011)](https://scholariq.org/papers/overview-of-regular-dialysis-treatment-in-scp-j-scp-apan-as-of-31-scp-d-scp/)
- [Atypical Hemolytic‐Uremic Syndrome: An Update on Pathophysiology, Diagnosis, and Treatment](https://scholariq.org/papers/atypical-hemolytic-uremic-syndrome-an-update-on-pathophysiology-diagnosis-and/)
- [Japanese Society for Dialysis Therapy Guidelines for Management of Cardiovascular Diseases in Patients on Chronic Hemodialysis](https://scholariq.org/papers/japanese-society-for-dialysis-therapy-guidelines-for-management-of/)
- [Acute Kidney Injury in Critically Ill Patients: A Prospective Randomized Study of Tidal Peritoneal Dialysis Versus Continuous Renal Replacement Therapy](https://scholariq.org/papers/acute-kidney-injury-in-critically-ill-patients-a-prospective-randomized-study-of/)
- [Quality of Life and Emotional Distress in Peritoneal Dialysis and Hemodialysis Patients](https://scholariq.org/papers/quality-of-life-and-emotional-distress-in-peritoneal-dialysis-and-hemodialysis/)
- [Liraglutide Improves Glycemic and Blood Pressure Control and Ameliorates Progression of Left Ventricular Hypertrophy in Patients with Type 2 Diabetes Mellitus on Peritoneal Dialysis](https://scholariq.org/papers/liraglutide-improves-glycemic-and-blood-pressure-control-and-ameliorates/)
- [Vascular access in therapeutic apheresis: One size does not fit all](https://scholariq.org/papers/vascular-access-in-therapeutic-apheresis-one-size-does-not-fit-all/)
- [A Case Report of Double‐Filtration Plasmapheresis for the Resolution of Refractory Chronic Urticaria](https://scholariq.org/papers/a-case-report-of-double-filtration-plasmapheresis-for-the-resolution-of/)

## Journal top topics

Showing 8 of 25.

- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)
- [Central Venous Catheters and Hemodialysis](https://scholariq.org/topics/central-venous-catheters-and-hemodialysis/)
- [Acute Kidney Injury Research](https://scholariq.org/topics/acute-kidney-injury-research/)
- [Pharmacological Effects and Toxicity Studies](https://scholariq.org/topics/pharmacological-effects-and-toxicity-studies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.